ETF Managers Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-114,087
| Closed | -$374K | – | 566 |
|
|
2019
Q4 | $374K | Sell |
114,087
-4,356
| -4% | -$14.3K | 0.01% | 300 |
|
|
2019
Q3 | $364K | Buy |
118,443
+13,083
| +12% | +$40.2K | 0.01% | 288 |
|
|
2019
Q2 | $253K | Buy |
105,360
+25,949
| +33% | +$62.3K | 0.01% | 302 |
|
|
2019
Q1 | $298K | Sell |
79,411
-2,561
| -3% | -$9.61K | 0.01% | 265 |
|
|
2018
Q4 | $294K | Buy |
81,972
+32,773
| +67% | +$118K | 0.01% | 268 |
|
|
2018
Q3 | $282K | Buy |
+49,199
| New | +$282K | 0.01% | 237 |
|
|
2018
Q2 | – | Sell |
-32,021
| Closed | -$160K | – | 626 |
|
|
2018
Q1 | $160K | Buy |
32,021
+5,315
| +20% | +$26.6K | 0.01% | 234 |
|
|
2017
Q4 | $166K | Buy |
26,706
+4,366
| +20% | +$27.1K | 0.01% | 215 |
|
|
2017
Q3 | $124K | Buy |
22,340
+1,413
| +7% | +$7.84K | 0.01% | 133 |
|
|
2017
Q2 | $97K | Buy |
+20,927
| New | +$97K | 0.01% | 184 |
|